S14G-Humanin improves cognitive deficits and reduces amyloid pathology in the middle-aged APPswe/PS1dE9 mice

Pharmacology Biochemistry and Behavior

Volumn 100, Issue 3, 2012, Pages 361-369

  Zhang, Wenjun ^a   Zhang, Wei ^a   Li, Zhuyi ^a   Hao, Jian ^a   Zhang, Zhuo ^a   Liu, Liu ^a   Mao, Ni ^a   Miao, Jianting ^a   Zhang, Lianfeng ^b  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b INSTITUTE OF LABORATORY ANIMAL SCIENCE   (China)

Author keywords

Alzheimer's disease; Amyloid beta protein; Cognitive deficits; Inflammation; S14G Humanin; Transgenic mice

Indexed keywords

AMYLOID; HUMANIN; S14G HUMANIN; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG EFFECT; FEMALE; LEARNING DISORDER; MEMORY DISORDER; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; WILD TYPE;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; ASTROCYTES; CALCIUM-BINDING PROTEINS; CEREBRAL CORTEX; COGNITION DISORDERS; CYTOKINES; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; MAZE LEARNING; MEMORY; MICE; MICE, TRANSGENIC; MICROFILAMENT PROTEINS; MICROGLIA; NOOTROPIC AGENTS; PEPTIDES; PLAQUE, AMYLOID; RANDOM ALLOCATION; SPECIFIC PATHOGEN-FREE ORGANISMS;

ANIMALIA; MUS; MUS MUSCULUS;

EID: 80054098429     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2011.09.012     Document Type: Article

References (52)

1. T. Arakawa, Y. Kita, T. Niikura A rescue factor for Alzheimer's diseases: discovery, activity, structure, and mechanism Curr Med Chem 15 2008 2086 2098
2. M. Blurton-Jones, M. Kitazawa, H. Martinez-Coria, N.A. Castello, F.J. Müller, and J.F. Loring et al. Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease Proc Natl Acad Sci USA 106 2009 13594 13599
3. O. Butovsky, M. Koronyo-Hamaoui, G. Kunis, E. Ophir, G. Landa, and H. Cohen et al. Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1 Proc Natl Acad Sci USA 103 2006 11784 11789 (Pubitemid 44182528)
4. J. Cappell, N. Herrmann, S. Cornish, K.L. Lanctôt The pharmacoeconomics of cognitive enhancers in moderate to severe Alzheimer's disease CNS Drugs 24 2010 909 927
5. D. Di Bona, G. Scapagnini, G. Candore, L. Castiglia, G. Colonna-Romano, and G. Duro et al. Immune-inflammatory responses and oxidative stress in Alzheimer's disease: therapeutic implications Curr Pharm Des 16 2010 684 691
6. D. Edbauer, E. Winkler, J.T. Regula, B. Pesold, H. Steiner, C. Haass Reconstitution of gamma-secretase activity Nat Cell Biol 5 2003 486 488
7. R. Fan, F. Xu, M.L. Previti, J. Davis, A.M. Grande, and J.K. Robinson et al. Minocycline reduces microglial activation and improves behavioral deficits in a transgenic model of cerebral microvascular amyloid J Neurosci 27 2007 3057 3063 (Pubitemid 46474134)
8. M. Garcia-Alloza, E.M. Robbins, S.X. Zhang-Nunes, S.M. Purcell, R.A. Betensky, and S. Raju et al. Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease Neurobiol Dis 24 2006 516 524 (Pubitemid 44716680)
9. J. Hardy, D.J. Selkoe The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 297 2002 353 356 (Pubitemid 34790756)
10. Y. Hashimoto, T. Niikura, H. Tajima, T. Yasukawa, H. Sudo, and Y. Ito et al. A rescue factor abolishing neuronal cell death by a wide spectrum of familial Alzheimer's disease genes and Abeta Proc Natl Acad Sci USA 98 2001 6336 6341 (Pubitemid 32488239)
11. N. Herrmann, A. Li, K. Lanctôt Memantine in dementia: a review of the current evidence Expert Opin Pharmacother 12 2011 787 800
12. J.J. Hoozemans, R. Veerhuis, J.M. Rozemuller, P. Eikelenboom Neuroinflammation and regeneration in the early stages of Alzheimer's disease pathology Int J Dev Neurosci 24 2006 157 165 (Pubitemid 43294622)
13. B.P. Imbimbo, L. Giardino, S. Sivilia, A. Giuliani, M. Gusciglio, and V. Pietrini et al. CHF5074, a novel gamma-secretase modulator, restores hippocampal neurogenesis potential and reverses contextual memory deficit in a transgenic mouse model of Alzheimer's disease J Alzheimers Dis 20 2010 159 173
14. H. Jin, T. Liu, W.X. Wang, J.H. Xu, P.B. Yang, and H.X. Lu et al. Protective effects of [Gly14]-Humanin on beta-amyloid-induced PC12 cell death by preventing mitochondrial dysfunction Neurochem Int 56 2010 417 423
15. S.S. Jung, W.E. Van Nostrand Humanin rescues human cerebrovascular smooth muscle cells from Abeta-induced toxicity J Neurochem 84 2003 266 272 (Pubitemid 36182268)
16. N.M. Kemppainen, S. Aalto, I.A. Wilson, K. Någren, S. Helin, and A. Brück et al. PET amyloid ligand [11C]PIB uptake is increased in mild cognitive impairment Neurology 68 2007 1603 1606 (Pubitemid 46717985)
17. G. Krejcova, J. Patocka, J. Slaninova Effect of humanin analogues on experimentally induced impairment of spatial memory in rats J Pept Sci 10 2004 636 639 (Pubitemid 39409623)
18. G. Kunesová, J. Hlavácek, J. Patocka, A. Evangelou, C. Zikos, and D. Benaki et al. The multiple T-maze in vivo testing of the neuroprotective effect of humanin analogues Peptides 29 2008 1982 1987
19. R. Lalonde, H.D. Kim, J.A. Maxwell, K. Fukuchi Exploratory activity and spatial learning in 12-month-old APP(695)SWE/co + PS1/DeltaE9 mice with amyloid plaques Neurosci Lett 390 2005 87 92 (Pubitemid 41415812)
20. N. Li, G.T. Liu The novel squamosamide derivative FLZ enhances BDNF/TrkB/CREB signaling and inhibits neuronal apoptosis in APP/PS1 mice Acta Pharmacol Sin 31 2010 265 272
21. A. Lleó, S.M. Greenberg, J.H. Growdon Current pharmacotherapy for Alzheimer's disease Annu Rev Med 57 2006 513 533 (Pubitemid 43262005)
22. T. Mamiya, M. Ukai [Gly(14)]-Humanin improved the learning and memory impairment induced by scopolamine in vivo Br J Pharmacol 134 2001 1597 1599 (Pubitemid 34038091)
23. T. Maurice, C. Hippert, N. Serratrice, G. Dubois, C. Jacquet, and C. Antignac et al. Cystine accumulation in the CNS results in severe age-related memory deficits Neurobiol Aging 30 2009 987 1000
24. J. Miao, M.P. Vitek, F. Xu, M.L. Previti, J. Davis, W.E. Van Nostrand Reducing cerebral microvascular amyloid-beta protein deposition diminishes regional neuroinflammation in vasculotropic mutant amyloid precursor protein transgenic mice J Neurosci 25 2005 6271 6277 (Pubitemid 40962521)
25. J. Miao, W. Zhang, R. Yin, R. Liu, C. Su, and G. Lei et al. S14G-Humanin ameliorates Abeta25-35-induced behavioral deficits by reducing neuroinflammatory responses and apoptosis in mice Neuropeptides 42 2008 557 567
26. R. Minkeviciene, P. Banerjee, H. Tanila Memantine improves spatial learning in a transgenic mouse model of Alzheimer's disease J Pharmacol Exp Ther 311 2004 677 682 (Pubitemid 39391555)
27. R. Minkeviciene, J. Ihalainen, T. Malm, O. Matilainen, V. Keksa-Goldsteine, and G. Goldsteins et al. Age-related decrease in stimulated glutamate release and vesicular glutamate transporters in APP/PS1 transgenic and wild-type mice J Neurochem 105 2008 584 594 (Pubitemid 351562711)
28. T. Mori, T. Town, J. Tan, N. Yada, Y. Horikoshi, and J. Yamamoto et al. Arundic Acid ameliorates cerebral amyloidosis and gliosis in Alzheimer transgenic mice J Pharmacol Exp Ther 318 2006 571 578 (Pubitemid 44061231)
29. T. Niikura, E. Sidahmed, C. Hirata-Fukae, P.S. Aisen, Y. Matsuoka A humanin derivative reduces amyloid Beta accumulation and ameliorates memory deficit in triple transgenic mice PLoS One 6 2011 e16259
30. T. Niikura, H. Tajima, Y. Kita Neuronal cell death in Alzheimer's disease and a neuroprotective factor, humanin Curr Neuropharmacol 4 2006 139 147
31. I. Nishimoto, M. Matsuoka, T. Niikura Unravelling the role of Humanin Trends Mol Med 10 2004 102 105 (Pubitemid 38293343)
32. E. O'Hare, D.I. Scopes, J.M. Treherne, K. Norwood, D. Spanswick, E.M. Kim RS-0406 arrests amyloid-beta oligomer-induced behavioural deterioration in vivo Behav Brain Res 210 2010 32 37
33. M. Oksman, H. Iivonen, E. Hogyes, Z. Amtul, B. Penke, and I. Leenders et al. Impact of different saturated fatty acid, polyunsaturated fatty acid and cholesterol containing diets on beta-amyloid accumulation in APP/PS1 transgenic mice Neurobiol Dis 23 2006 563 572 (Pubitemid 44234092)
34. T.P. O'Leary, R.E. Brown Visuo-spatial learning and memory deficits on the Barnes maze in the 16-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease Behav Brain Res 201 2009 120 127
35. Y. Peng, J. Sun, S. Hon, A.N. Nylander, W. Xia, and Y. Feng et al. L-3-n-butylphthalide improves cognitive impairment and reduces amyloid-beta in a transgenic model of Alzheimer's disease J Neurosci 30 2010 8180 8189
36. A.J. Rozemuller, W.A. van Gool, P. Eikelenboom The neuroinflammatory response in plaques and amyloid angiopathy in Alzheimer's disease: therapeutic implications Curr Drug Targets CNS Neurol Disord 4 2005 223 233 (Pubitemid 40754159)
37. L. Ruan, Z. Kang, G. Pei, Y. Le Amyloid deposition and inflammation in APPswe/PS1dE9 mouse model of Alzheimer's disease Curr Alzheimer Res 6 2009 531 540
38. A. Savonenko, G.M. Xu, T. Melnikova, J.L. Morton, V. Gonzales, and M.P. Wong et al. Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities Neurobiol Dis 18 2005 602 617 (Pubitemid 40332718)
39. D. Schenk Current challenges for the successful treatment and prevention of Alzheimer's disease: treating the pathologies of the disease to change its clinical course Alzheimers Dement 4 2008 S119 S121
40. D.J. Selkoe Alzheimer's disease: genes, proteins, and therapy Physiol Rev 81 2001 741 766 (Pubitemid 32267077)
41. D.J. Selkoe Cell biology of the amyloid beta-protein precursor and the mechanism of Alzheimer's disease Annu Rev Cell Biol 10 1994 373 403 (Pubitemid 24372824)
42. B. Seltzer Cholinesterase inhibitors in the clinical management of Alzheimer's disease: importance of early and persistent treatment J Int Med Res 34 2006 339 347 (Pubitemid 44363567)
43. M. Smith, J. Wells, M. Borrie Treatment effect size of memantine therapy in Alzheimer disease and vascular dementia Alzheimer Dis Assoc Disord 20 2006 133 137 (Pubitemid 44259785)
44. P.H. St George-Hyslop, A. Petit Molecular biology and genetics of Alzheimer's disease C R Biol 328 2005 119 130 (Pubitemid 40247057)
45. H. Tajima, M. Kawasumi, T. Chiba, M. Yamada, K. Yamashita, and M. Nawa et al. A humanin derivative, S14G-HN, prevents amyloid-beta-induced memory impairment in mice J Neurosci Res 79 2005 714 723 (Pubitemid 40476451)
46. R.J. Van Marum Current and future therapy in Alzheimer's disease Fundam Clin Pharmacol 22 2008 265 274 (Pubitemid 351712889)
47. H. Wang, J. Liu, Y. Zong, Y. Xu, W. Deng, and H. Zhu et al. miR-106b aberrantly expressed in a double transgenic mouse model for Alzheimer's disease targets TGF-β type II receptor Brain Res 1357 2010 166 174
48. X. Wang, P. Liu, H. Zhu, Y. Xu, C. Ma, and X. Dai et al. miR-34a, a microRNA up-regulated in a double transgenic mouse model of Alzheimer's disease, inhibits bcl2 translation Brain Res Bull 80 2009 268 273
49. X. Xu, C.C. Chua, J. Gao, R.C. Hamdy, B.H. Chua Humanin is a novel neuroprotective agent against stroke Stroke 37 2006 2613 2619 (Pubitemid 44454687)
50. H. Yamakawa, S. Yagishita, E. Futai, S. Ishiura beta-Secretase inhibitor potency is decreased by aberrant beta-cleavage location of the "Swedish mutant" amyloid precursor protein J Biol Chem 285 2010 1634 1642
51. L. Zhang, Y. Xing, C.F. Ye, H.X. Ai, H.F. Wei, L. Li Learning-memory deficit with aging in APP transgenic mice of Alzheimer's disease and intervention by using tetrahydroxystilbene glucoside Behav Brain Res 173 2006 246 254 (Pubitemid 44291828)
52. W. Zhang, J. Hao, R. Liu, Z. Zhang, G. Lei, and C. Su et al. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease Behav Brain Res 222 2011 342 350